In 2024, domestic and foreign equity holders sold shares worth over $30 billion via block deals, showcasing sustained ...

The "North America Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others" report has been added to ResearchAndMarkets.com's offering.The North American orthobiologics ...

President-elect Donald Trump and his incoming administration are unlikely to attempt a wholesale restructuring of U.S.

By Gnaneshwar Rajan and Maggie Fick (Reuters) -U.S.-based vaccine maker Novavax said on Wednesday it will sell its ...

In older patients discharged after hospitalization for heart failure, many spend the majority of the first year alive and at home.

IGM Biosciences has pivoted from cancer therapeutics to autoimmune diseases despite setbacks, showing a 25% stock increase since last October. Click for more on IGMS.

Not exactly known for its dealmaking, Sarepta Therapeutics has thrown down a massive wad of cash to work with Arrowhead ...

Navitas Semiconductor is losing money according to Jim Cramer. LandBridge Company is a winner, while Regeneron is facing ...

Comparison measures of lung function and improved categorization of cardiovascular disease (CVD) risk were among the key ...

The Chinese government's policies promoting opening up and innovation, as well as the excellent business environment it fosters for foreign enterprises, have injected strong confidence into Sanofi's ...

Novavax sells manufacturing facility to Novo Nordisk for $200M, enabling Novavax to advance growth strategy and drive value ...

COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker ...